SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 102 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,624,000 | +21.3% | 175,233 | -1.5% | 0.00% | 0.0% |
| Q1 2016 | $2,164,000 | -10.4% | 177,927 | +17.3% | 0.00% | 0.0% |
| Q4 2015 | $2,414,000 | +6.9% | 151,738 | +3.0% | 0.00% | 0.0% |
| Q3 2015 | $2,258,000 | -36.5% | 147,301 | +0.7% | 0.00% | -50.0% |
| Q2 2015 | $3,556,000 | +5.0% | 146,297 | +0.4% | 0.00% | 0.0% |
| Q1 2015 | $3,386,000 | +4.4% | 145,643 | +12.7% | 0.00% | 0.0% |
| Q4 2014 | $3,243,000 | -14.8% | 129,183 | +5.6% | 0.00% | 0.0% |
| Q3 2014 | $3,805,000 | +22.1% | 122,368 | +1.5% | 0.00% | 0.0% |
| Q2 2014 | $3,116,000 | +13.4% | 120,511 | +2.5% | 0.00% | 0.0% |
| Q1 2014 | $2,748,000 | -24.2% | 117,623 | -17.7% | 0.00% | -33.3% |
| Q4 2013 | $3,627,000 | +49.9% | 142,947 | +20.6% | 0.00% | +50.0% |
| Q3 2013 | $2,419,000 | +99.8% | 118,575 | +105.4% | 0.00% | +100.0% |
| Q2 2013 | $1,211,000 | – | 57,724 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|